Neoplasia/BPH

	Beyond the stone: nephrolithiasis as a metabolic sentinel in upper tract urothelial carcinoma and papillary renal cell carcinoma: toward a risk-stratified management framework. Int Urol Nephrol Wan S, Gao S, Huang K, Bai Y. PMID: 42184081 [PubMed - as supplied by publisher]
	A nomogram predicting the OS and CSS ofâ€‰â‰¥â€‰T1b renal cell carcinoma patients after surgery. Clin Transl Oncol Zheng J, Wang H, Lv J, Liu C, Lan X, Xu T, Feng M. PMID: 42184075 [PubMed - as supplied by publisher]
	Improving Clear Cell Renal Cell Carcinoma Diagnosis: Modified CT Algorithms with Simplified Heterogeneity Scoring. Ann Surg Oncol Zhang W, Chen Q, Zhu X, Li X, Wang X, Ma H, Song X, Zheng Z, Qu J. PMID: 42183967 [PubMed - as supplied by publisher]
	Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer. Ther Adv Med Oncol Bilen MA, Lowentritt BH, Burbage S, Patel C, Rossi C, Kinkead F, Wong G, Pilon D, Shore ND. PMID: 42182602 [PubMed]
	Identification of shared diagnostic biomarkers and molecular pathways between chronic kidney disease and renal cell carcinoma using transcriptomics and machine learning. Transl Cancer Res Peng X, Wang Z, Si J, Ji H, Xu G, Chen Y, Du M, Xu M. PMID: 42180890 [PubMed]
	Low follow-up rate after positive prostate cancer screening in southern China: a community-based cross-sectional survey with a prospective component. Front Public Health Li ZQ, Li JR, Li Y, Liang YF, Bi JW, Li W. PMID: 42180501 [PubMed - indexed for MEDLINE]
	Application and challenges of smart responsive multifunctional nanoplatforms in integrated diagnosis and treatment of bladder cancer and overcoming therapeutic resistance. Front Oncol Chen L, Hang G, Wen Q, Ren L, Chen B. PMID: 42180091 [PubMed]
	Association between BK polyomavirus and prostate cancer: a systematic review and meta-analysis. Front Oncol Xiang B, Wang S, Zhang X, Zhao J, Zhang M, He J. PMID: 42180090 [PubMed]
	Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review. Front Oncol Cleanclay WD, Kintung IF, Kernyuy FB, Yensii NG, Fagbohun BO, Amadi EC, Kaze NN. PMID: 42180075 [PubMed]
	A prospective comparison of the diagnostic performance of a high b-value diffusion-weighted image-guided score versus PI-RADS v2.1 for transition zone prostate cancer. Front Oncol Li K, Xu T, Yan X, Mi S, Jiang M, Chen L, Kuang F. PMID: 42180067 [PubMed]
	JS-K induces autophagy-dependent ferroptosis in bladder cancer: a multimodal mechanistic and translational study. Precis Clin Med Li Z, Zhong H, Baptista-Hon D, Qiu J, Zhang Z, Zhang X, Zhao Y, Zhu L, Gao S, Li B, Monteiro O, Liu J, Zhuo Y. PMID: 42179765 [PubMed]
	Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND-XR. Andrology Saab MM, Hegarty J, Gleeson JP, Murphy D, McHugh S, Shiely F, Murphy A, Kirby A, Korfage IJ, Terhaard S, van der Heide A, Sivesgaard J, Seidler MK, Patrikidou A, Je, Corrigan L, Sheehan PK, Raggi D, Reid A, Chovanec M, Gianntempo P, Gietema JA, van der Feen JF, Lupiáñez-Villanueva F, Roca-Umbert A, Reid J, Alves P, Soares J, Galvin K, Kubo M, O'Malley M. PMID: 42179065 [PubMed - as supplied by publisher]
	Efficacy of Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis Assessed by Modified MD Anderson Criteria: An Open-Label Phase 2 Study. Int J Urol Hongo F, Nakai Y, Nozawa M, Kato T, Kamikawa S, Tamada S, Yamada K, Soeda J, Tsubouchi R, Osaka T, Uemura H. PMID: 42179010 [PubMed - indexed for MEDLINE]
	Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes. Radiother Oncol Mathew JM, Bacon H, Winter J, Bernstein J, Liu ZA, Kong V, Dang J, Wang K, Chung P, Bayley A, Berlin A, Catton C, Gutierrez E, Mesci A, McPartlin A, Raman S, Alibhai S, Taylor E, Warde P, Glicksman RM. PMID: 42177994 [PubMed - as supplied by publisher]
	Comparative fall risk of patients treated with novel androgen receptor antagonists in prostate cancer: a systematic review and meta-analysis. BMC Cancer Wei C, Cai Y, Huang Z, Dai J, Mo S, Ling L. PMID: 42177476 [PubMed - as supplied by publisher]
	Transcriptomic insights into epigenetic and immunomodulatory roles of nuclear histone genes in bladder cancer: A bioinformatics approach. Adv Protein Chem Struct Biol Elavarasu SM, Asheem I, M N, S UK, Magesh R, K S, C GPD. PMID: 42177073 [PubMed - indexed for MEDLINE]
	Elective Nodal Radiotherapy in Localized Prostate Cancer: A Meta-Analysis. Int J Radiat Oncol Biol Phys Roy S, Jia AY, Zaorsky NG, Spratt DE. PMID: 42176865 [PubMed - as supplied by publisher]
	Improving physical activity in men with prostate cancer through wearable devices and online education: Randomized controlled trial. Int J Med Inform O'Neill M, Sabiston CM, Tomlinson G, Santa Mina D, Sibley D, Alibhai SMH. PMID: 42176601 [PubMed - as supplied by publisher]
	Thromboembolic Events after Surgery for Localized Prostate Cancer: Incidence, Risk Factors, and Survival Outcomes. Clin Appl Thromb Hemost Noh Y, Park H, Shin DY, Hong J, Cho H, Byun JM, Koh Y, Jeong SH, Yuk H, Cho SY, Jeong CW, Ku JH, Kwak C, Kim I. PMID: 42175944 [PubMed - indexed for MEDLINE]
	Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysis. Cancer Zeng J, Chen MH, Wu J, Xie W, Ravi P, Nguyen P, Sandler H, D'Amico AV. PMID: 42175549 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188084

Page 1 of 9405



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy